| Date Filed | Type | Description |
| 10/06/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Acquired 14,675 shares
@ $0 |
|
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 6,800 shares
@ $0
Granted 19,500 options to buy
@ $19.6, valued at
$382.2k
|
|
| 06/12/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 60,000 options to buy
@ $1.39, valued at
$83.4k
|
|
| 06/02/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 05/11/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Disposed of 40,567 options to buy
@ $0.7683, valued at
$31.2k
Acquired 40,567 options to buy
@ $0.7683, valued at
$31.2k
Disposed of 86,206 options to buy
@ $5.8766, valued at
$506.6k
Acquired 86,206 options to buy
@ $5.8766, valued at
$506.6k
Disposed of 28,675 options to buy
@ $5.8766, valued at
$168.5k
Acquired 28,675 options to buy
@ $5.8766, valued at
$168.5k
Disposed of 23,243 options to buy
@ $18, valued at
$418.4k
Acquired 23,243 options to buy
@ $18, valued at
$418.4k
|
|
| 05/04/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Granted 23,243 options to buy
@ $18, valued at
$418.4k
|
|
| 05/04/2023 |
3
| Machado Patrick (Director) has filed a Form 3 on ACELYRIN, Inc. |
| 08/17/2022 |
4
| Machado Patrick (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $29.56, valued at
$886.8k
Disposed/sold 8,500 options to buy
@ $65.39, valued at
$555.8k
Disposed/sold 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 06/29/2022 |
4
| Machado Patrick (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,000 options to buy
@ $30.11, valued at
$542k
|
|
| 06/24/2022 |
4
| Machado Patrick (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 50,000 options to buy
@ $1.82, valued at
$91k
|
|
| 06/16/2022 |
4
| Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 4,100 shares
@ $0
Granted 16,800 options to buy
@ $20.62, valued at
$346.4k
|
|
| 06/14/2022 |
4
| Machado Patrick (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9903, valued at
$39.6k
Granted 12,500 options to buy
@ $0.9903, valued at
$12.4k
|
|
| 10/01/2021 |
3
| Machado Patrick (Director) has filed a Form 3 on Roivant Sciences Ltd. |
| 06/25/2021 |
4
| Machado Patrick (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 35,000 options to buy
@ $7.84, valued at
$274.4k
|
|
| 06/07/2021 |
4
| Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 14,100 options to buy
@ $24.79, valued at
$349.5k
|
|
| 06/04/2021 |
4
| Machado Patrick (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 06/03/2021 |
4
| Machado Patrick (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 10,000 options to buy
@ $18.56, valued at
$185.6k
|
|
| 05/14/2021 |
4
| Machado Patrick (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.7, valued at
$148k
Granted 12,500 options to buy
@ $3.7, valued at
$46.3k
|
|
| 03/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Machado Patrick (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 10,000 shares
@ $11.5174, valued at
$115.2k
|
|
| 11/05/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 20,000 options to buy
@ $11.85, valued at
$237k
|
|
| 11/05/2020 |
3
| Machado Patrick (Director) has filed a Form 3 on Xenon Pharmaceuticals Inc. |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 30,000 options to buy
@ $25.64, valued at
$769.2k
|
|
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 35,000 options to buy
@ $2.85, valued at
$99.8k
|
|
| 06/08/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 06/08/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 14,000 options to buy
@ $30.05, valued at
$420.7k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2019 |
4
| Machado Patrick (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $8.55, valued at
$427.5k
|
|
| 12/12/2019 |
3
| Machado Patrick (Director) has filed a Form 3 on Arcus Biosciences, Inc. |
| 08/02/2019 |
4
| Machado Patrick (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 45,000 options to buy
@ $13.41, valued at
$603.5k
|
|
| 07/16/2019 |
SC 13D/A
| Machado Patrick reports a 0% stake in Axovant Gene Therapies Ltd. |
|